Artemis Global Life Sciences Ltd((Merged)

Artemis Global Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Artemis Global Life Sciences Ltd((Merged)

₹ 49.4 -3.23%
23 Oct 2019
aglsl.in BSE: 540616 NSE: AGLSL
About

Artemis Global Life Sciences is engaged in Healthcare Services.

[ add key points ]
Website BSE NSE
  • Market Cap ₹ 327 Cr.
  • Current Price ₹ 49.4
  • High / Low ₹ /
  • Stock P/E 15.6
  • Book Value ₹ 44.3
  • Dividend Yield 0.00 %
  • ROCE 13.6 %
  • ROE 7.61 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Stock is trading at 1.12 times its book value

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019
119.30 126.22 120.16 137.33 126.43 140.89 139.04 140.16 135.71
108.81 113.88 109.63 111.76 114.71 123.82 121.92 122.25 120.91
Operating Profit 10.49 12.34 10.53 25.57 11.72 17.07 17.12 17.91 14.80
OPM % 8.79% 9.78% 8.76% 18.62% 9.27% 12.12% 12.31% 12.78% 10.91%
1.13 1.28 0.90 1.06 1.17 0.89 0.63 1.31 0.59
Interest 2.07 2.62 2.14 2.59 2.03 2.99 3.10 2.88 3.28
Depreciation 4.35 4.94 4.77 4.74 4.90 4.96 5.02 5.20 5.45
Profit before tax 5.20 6.06 4.52 19.30 5.96 10.01 9.63 11.14 6.66
Tax % 37.69% 38.61% 27.21% 17.20% 38.59% 36.56% 49.01% 50.90% 35.89%
3.24 3.73 3.30 15.97 3.65 6.35 4.91 5.47 4.27
EPS in Rs 0.49 0.56 0.50 2.41 0.55 0.96 0.74 0.83 0.65
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 TTM
463 503 547 556
411 443 481 489
Operating Profit 52 60 66 67
OPM % 11% 12% 12% 12%
5 3 2 3
Interest 9 9 11 12
Depreciation 15 19 20 21
Profit before tax 33 35 37 37
Tax % 17% 25% 45%
27 26 20 21
EPS in Rs 4.10 3.97 3.10 3.18
Dividend Payout % 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 9%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -21%
Stock Price CAGR
10 Years: %
5 Years: 0%
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 8%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019
Equity Capital 13 13 13
Reserves 234 260 280
94 91 76
129 133 185
Total Liabilities 469 497 554
326 352 381
CWIP 27 43 49
Investments 0 0 0
116 102 124
Total Assets 469 497 554

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019
52 71 40
-70 -67 -50
22 -10 14
Net Cash Flow 4 -5 5

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019
Debtor Days 48 40 52
Inventory Days
Days Payable
Cash Conversion Cycle 48 40 52
Working Capital Days -24 -26 -36
ROCE % 13% 14%

Shareholding Pattern

Numbers in percentages

Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019
69.82% 69.82% 69.82% 69.82% 69.82% 69.82% 69.82% 69.82% 69.82% 69.82%
0.09% 0.00% 0.00% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.91% 0.91% 0.91% 0.91% 0.91% 0.92% 0.95% 1.17% 1.17% 1.22%
2.27% 2.27% 7.37% 7.37% 7.37% 7.37% 7.37% 7.37% 7.37% 7.37%
26.91% 27.00% 21.90% 21.89% 21.90% 21.89% 21.86% 21.64% 21.64% 21.59%
No. of Shareholders 7,2417,0656,7696,4676,4266,3236,2426,2566,1806,110

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports